Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy by Shivananda Nayak, B et al.
© 2008 Nayak et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Vascular Health and Risk Management 2008:4(1) 243–247 243
ORIGINAL RESEARCH
Correlation of microalbumin and sialic acid 
with anthropometric variables in type 2 diabetic 
patients with and without nephropathy
B Shivananda Nayak
Heidi Duncan
Sunita Lalloo
Kevin Maraj
Vani Matmungal
Felicia Matthews
Bhupinder Prajapati
Ria Samuel
Pearse Sylvester
Department of Preclinical Sciences, 
Biochemistry Unit, The University of 
the West Indies, Trinidad, West Indies
Correspondence: B Shivananda Nayak
Dept of Pre-Clinical Sciences, Faculty of 
Medical Sciences, The University of the 
West Indies, Trinidad and Tobago
Tel +1 868 6621873 x4642
Fax +1 868 6621873
Email snayak@fms.uwi.tt
Aim: The objective of this study is to correlate microalbumin and sialic acid levels with anthro-
pometric variables in type 2 diabetic patients with and without nephropathy.
Methods: This study was a case control study and included 108 Trinidadian subjects (aged 
15–60 years) of which 30 were healthy individuals, 38 had type 2 diabetes, and 40 were of 
type 2 diabetic patients with nephropathy. Blood pressure and waist to hip ratio were recorded. 
Fasting venous blood samples and urine samples were collected from all the subjects. Blood 
samples were analysed for the glucose, C-reactive protein, and sialic acid. Urine sample was 
analysed for microalbumin and sialic acid.
Results: Urinary microalbumin was higher among diabetic subjects (28.9 ± 30.3 mg/L) com-
pared with controls (8.4 ± 10.2 mg/L) and was signiﬁ  cantly higher in diabetic patients with 
nephropathy (792.3 ± 803.9 mg/L). Serum sialic acid was higher in subjects with diabetic 
nephropathy (71.5 ± 23.3 mg/dL) compared to diabetics (66.0 ± 11.7 mg/dL) and controls 
(55.2 ± 8.3 mg/dL). Increased microalbumin and sialic acid were correlated with other cardio-
vascular risk factors such as hypertension and waist to hip ratios (p   0.05).
Conclusions: From these results it can be concluded that the increased microalbumin and 
sialic acid were strongly correlated with hypertension and waist to hip ratios in Trinidadian 
type-2 diabetic patients. Measurement of sialic acid, microalbumin, and waist to hip ratio 
along with the blood pressure is recommended for all type 2 diabetic patients to reduce the 
cardiovascular risk.
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Introduction
Diabetes, a life long progressive disease, is the result of body’s inability to produce 
insulin or use insulin to its full potential, and is characterized by high circulating 
glucose. This disease has reached epidemic proportions and has become one of the 
most challenging health problems of the 21st century. It affects more than 230 million 
people worldwide, and this number is expected to reach 350 million by 2025. Accord-
ing to the World Health Organisation there were approximately 60,000 people living 
with diabetes in Trinidad and Tobago in the year 2000, and this number is expected 
to increase to 125,000 in the year 2030. The majority of these people suffer from 
type 2 diabetes, which is indicative of the high prevalence diabetes mellitus among 
Trinidadians. The disease cannot be cured but it can be controlled. The chronic hyper-
glycemia of diabetes is associated with signiﬁ  cant long-term sequelae, particularly 
damage, dysfunction, and failure of various organs especially the kidneys, eyes, nerves, 
heart, and blood vessels.
Cardiovascular disease (CVD), one of the complications of diabetes mellitus has 
been found to be partly due to low grade of systemic inﬂ  ammation (Haffner et al 2002). 
In the Atherosclerosis Risk in Communities (ARIC) study, there was a positive link Vascular Health and Risk Management 2008:4(1) 244
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between systemic inﬂ  ammation and the development of type 
2 diabetes, but this link was seen only in white non-smokers. 
The link was neither seen among African Americans nor 
among smokers (Duncan et al 2003). Low-grade systemic 
inﬂ  ammation has been linked to and may be used to pre-
dict the onset of both type 2 diabetes and cardiovascular 
disease.
Sialic acid-rich glycoprotein is found mainly in cell 
membranes (Yarema 2006), and elevated levels may indicate 
excessive cell membrane damage, but more speciﬁ  cally for 
cells of vascular tissue. Damage to vascular tissue leads 
to ischemia which most affects the smallest blood vessels, 
particularly in the retina, kidneys, heart and brain. Sialic acid 
can be used as a measurement of the acute phase response 
because many proteins of the immune response are actually 
glycoproteins, and these glycoproteins have sialic acid as 
the terminal sugar on their oligosaccharide chain (Pickup 
et al 2004).
Microalbuminuria, the dominant feature of diabetic 
nephropathy is deﬁ  ned as an albumin excretion rate of 20–
300 mg/24 hrs. This study was planned to determine micro-
albumin, and sialic acid levels in Trinidadian type 2 diabetic 
patients with and without nephropathy and correlate these 
with anthropometric variables. This information is not avail-
able for the multiethnic society that is present in Trinidad. 
Our earlier research demonstrated a positive correlation in 
the Indian population and measurement of inﬂ  ammation 
sensitive markers may be useful to assess cardiovascular risk 
in diabetic patients (Nayak et al 2005). Since the Trinidadian 
population comprises a signiﬁ  cant proportion of descen-
dants of East Indian immigrants, information on a marker 
of cardiovascular risk among diabetics in Trinidad would 
allow medical practitioners to better manage their diabetic 
patients to prevent complications, improve life expectancy, 
and quality of life.
Methods
This was a case-control study comparing the concentrations 
of inﬂ  ammatory markers and anthropometric variables in 
Trinidadians with and without type 2 diabetes. The study 
included 108 subjects (aged 15–60 years) of which 30 were 
healthy individuals, 38 patients had type 2 diabetes, and 
40 patients had type 2 diabetes with nephropathy. The Ethics 
committee of the Faculty of Medical Sciences, University 
of the West Indies approved the study. We informed every 
patient of the details of the study in individual interviews, 
and all the provided written informed consent. All subjects 
were reported in the morning after an overnight fast of at 
least ten hours. Standing height and weight were measured. 
Body mass index (BMI) deﬁ  ned as weight in kg/height 
(meters) squared was used as an index of obesity. To deter-
mine waist-to-hip ratio, the standardized clinician’s tape 
measure was placed around the widest part of the hips and 
then placed around the narrowest part of the waist above the 
belly button and waist measurement was divided by the hip 
measurement. Blood pressure was measured according to 
the standard procedure.
Fasting blood and urine samples were collected from 
subjects. Serum glucose was measured by hexokinase method 
(Stat Fax), serum C-reactive protein and urine microalbu-
min were measured with a Nycocard reader (point of care 
instrument designed for rapid and reliable measurements of 
microalbumin, CRP and HbA1c).
Serum and urinary sialic acid were measured by a 
spectrophotometric assay (Winzler 1955). Serum (or urine) 
0.15 ml was mixed with 3.60 ml of 5% TCA and the tubes 
were covered with marbles and kept in a boiling water bath 
for 15 minutes. The tubes were cooled and centrifuged for 
10 minutes at 2000 g. The supernatant (1.0 ml) was mixed 
with 2.0 ml each of acid reagent and diphenylamine reagent. 
Standard and blank samples were treated in the same way. 
The contents were mixed using a vertex mixer, covered with 
marbles and placed in a boiling water bath for 30 minutes. 
Development of a purple color was measured on a spectro-
photometer at 540 nm.
Sample speciﬁ  cation
Trinidadian subjects between 15–60 years (mean age 
of 50 ± 15) comprising almost equal numbers of males 
and females in all groups were included. Subjects were 
required to be a) in good overall health with normal fasting 
blood glucose (controls), b) with type 2 diabetes and no 
complications, and c) type 2 diabetes with nephropathy. The 
exclusion criteria were: a) persons with type 1 diabetes, b) 
persons with current or recent medical condition which could 
affect concentrations of inﬂ  ammatory markers (for instance, 
cancer), c) persons taking cholesterol-lowering medication, 
d) pregnant women, and e) heavy smokers (more than one 
pack of cigarettes per day).
Demographic data collected were: age, gender, and eth-
nicity. Potential confounding variables were diet, physical 
activity, and obesity.
Statistical method
Results were expressed as mean ± SD. Data were analyzed 
using the statistical package for social science (SPSS). The Vascular Health and Risk Management 2008:4(1) 245
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comparisons within and among group were done using one 
way ANOVA test. The p value   0.05 was set as the level 
of signiﬁ  cance because the distribution of most variables 
was not symmetric. Pearson’s correlation test was used to 
test correlation.
Results
Table 1 shows the biochemical and anthropometric 
variables in Trinidadians with type 2 diabetes mellitus 
with and without nephropathy. There was a significant 
difference (p   0.000) in serum sialic acid concentrations 
between at least two means; hence the null hypothesis is 
rejected. Serum sialic acid concentrations were signifi-
cantly higher among the diabetic subjects (67.0 ± 11.7 
mg/dL) as compared to the controls (54.2 ± 8.3 dL) 
(p < 0.01) (Figure 1). Increased serum sialic acid was 
found among diabetics with nephropathy (72.5 ± 22.3 
mg/dL) as compared with the controls (p   0.000) 
(Figure 1). Urinary microalbumin in diabetic nephropathy 
patients was significantly higher 792.3 ± 803.9 mg/L) 
compared with diabetics (28.9 ± 30.3) and healthy indi-
viduals (8.4 ± 10.2 mg/L).
The waist-to-hip ratios of the diabetics (0.98 ± 0.07) 
and nephropathic diabetics subjects (0.99 ± 0.06) were 
significantly higher than the controls (0.86 ± 0.06) 
(p < 0.000). Systolic blood pressure was significantly 
higher in diabetics (145.4 ± 22.5 mmHg) and diabetic 
nephropathy (162.3 ± 26.0 mmHg) subjects when 
compared with the controls (123.9 ± 14.6 mmHg) 
(p   0.000).
Fasting blood glucose was signiﬁ  cantly high among 
diabetics (p   0.05). There was no signiﬁ  cant change in 
the concentrations of C-reactive protein and BMI between 
the three study groups. Serum sialic acid was signiﬁ  cantly 
correlated with urine albumin (p   0.01), waist-to-hip ratio 
(p   0.05) and systolic blood pressure (p   0.01). This study 
demonstrated good correlation between serum sialic acid and 
the other anthropometric variables.
Discussion
This study found sialic acid can be used as a potential inﬂ  am-
matory marker for diabetes mellitus (Crook et al 2001). Previ-
ous reports have also indicated that elevated serum sialic acid 
(SSA) concentrations were associated with an increased risk 
of cardiovascular disease and microvascular diabetes related 
complications (Lindberg et al 1991). Our study primarily 
focuses on the relationship between inﬂ  ammatory markers 
and anthropometric variables. Earlier studies have indicated 
that SSA concentrations are elevated in diabetics (both type 1 
and type 2) with and without nephropathy, while others have 
reported no such correlation (Abdella et al 2000; Crooket al 
2002). Studies have also found that the presence or absence 
Table 1 Biochemical and anthropometric variables in the controls, diabetics, and diabetics without nephropathy
Variable Controls  (Mean  ± SD)  Diabetics (Mean ± SD)  Diabetes with nephropathy
 n  = 30  n = 38  (Mean ± SD) n = 40
BMI (kg/m2) 27.9  ± 7.3  29.2 ± 9.5  27.1 ± 6.1
Waist-to-hip ratio  0.86 ± 0.06  0.98 ± 0.07*  0.99 ± 0.06*
Systolic blood pressure (mmHg)  123.9 ± 14.6  145.4 ± 22.5*  162.3 ± 26.0*
Serum sialic acid (mg/dL)  54.2 ± 8.3  67.0 ± 11.7*  72.5 ± 22.3*
Urine sialic acid (mg/dL)  29.1 ± 15.2  38.6 ± 28.5  36.0 ± 38.9
Microalbumin (mg/L)  8.4 ± 10.2   28.9 ± 30.3   792.3 ± 803.9 
C-reactive protein (mg/L)  2.0 ± 2.1  3.2 ± 4.2  3.4 ± 6.4
Glucose (mg/dL)  88.8 ± 9.8  135.6 ± 44.3*  154.9 ± 74.9*
Notes: *p   0.05, signiﬁ  cant compared with controls.
Figure 1 Mean sialic acid concentrations in three study groups.Vascular Health and Risk Management 2008:4(1) 246
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of this trend may be related to ethnicity (Lindberg et al 
1997). Our ﬁ  ndings indicate a signiﬁ  cant increase in SSA 
concentrations in diabetic patients in comparison to controls 
even for patients with diabetic nephropathy.
Differences between SSA concentrations and controls 
were more significant (p   0.000) for those with dia-
betic nephropathy than for diabetics without nephropathy 
(p   0.010). Serum sialic acid is generally bound to acute 
phase proteins (Melajarvi et al 1996) and possible explanations 
for the increase in SSA concentrations have been put forward. 
Research studies have shown that the concentration of sialic 
acid in serum is elevated in pathological states when there is 
tissue damage, tissue proliferation and inﬂ  ammation. Studies 
have also indicated that vascular permeability is regulated by 
sialic acid moieties. The vascular endothelium carries a high 
concentration of sialic acid and hence extensive microvascu-
lar damage associated with non-insulin dependant diabetes 
mellitus (NIDDM), could account for its shedding into the 
circulation leading to an increase in vascular permeability 
and overall increased SSA concentrations (Crook et al 2001). 
Tissue injury caused by diabetic vascular complications 
stimulates local cytokine secretion from cellular inﬁ  ltrates 
such as macrophages and endothelial cells. This induces an 
acute phase response with release of acute phase glycopro-
teins with sialic acid from the liver into the general circulation 
again leading to increased SSA concentrations (Crook et al 
2001). Another plausible explanation for the increased SSA 
is that there may be a difference in the ratio between the 
two forms of erythrocyte sialidases which are important in 
maintaining the viability of the erythrocyte and its survival 
in the circulating blood (Traving et al 1998).
The increase in urine albumin in the diabetics compared 
with the controls can be interpreted as an early sign of 
nephropathic changes in those individuals. Increase in urine 
albumin seen with diabetic nephropathy can be attributed 
to degradation of the glomerular basement membranes and 
hypertension, both characteristic of diabetic nephropathy 
(Phillip et al 2006). The presence of microalbuminuria is 
a marker of endothelial dysfunction whether or not it is 
progressive, and indices an increased risk of generalized 
atherosclerosis and increased mortality from cardiovascular 
disease (English et al 2001).
The positive correlation between urine albumin levels and 
serum sialic acid was seen in earlier studies (Chen et al 1996). 
The actual cause of this occurrence is not known; however, 
several researchers have proposed a variety of mechanisms. 
One such mechanism includes the shedding of sialic acid into 
the circulation as a result of vascular endothelial damage. 
Vascular damage is seen throughout the body including the 
kidneys especially in diabetic nephropathy. Consequently, 
there is increased ﬁ  ltration of albumin via the damaged 
glomeruli and hence an increased albumin loss in the urine 
(Yokayama et al 1996). Blood pressure and microalbuminuria 
are also risk factors for cardiovascular disease. Therefore 
it can be concluded that sialic acid may be considered as a 
possible marker for cardiovascular disease. Previous studies 
also showed showed a positive association between SSA and 
systolic blood pressure and urine albumin excretion (Crook 
et al 1993, 1994).
We found a positive correlation between waist to hip 
ratio and SSA, but not with BMI. This indicates that central 
adiposity may be an important marker of NIDDM as opposed 
to general obesity since waist to hip ratio is a speciﬁ  c indica-
tor of central adiposity (Favier et al 2005). Central adiposity 
being a cardiovascular risk factor, these patients may have 
underlying microvascular complications which may explain 
the correlation observed with SSA (Welborn et al 2003). 
Researchers also showed that sialic acid but not CRP, is 
signiﬁ  cantly associated with one or the other features of 
metabolic syndrome, independent of BMI (Browning et al 
2004), further supporting the use of SSA as a marker for 
cardiovascular risk. The insigniﬁ  cant increase in the CRP 
levels among the three groups could be explained by the 
inherent inﬂ  ammatory state in diabetics with and without 
complications (Raz et al 2003). There was also no correlation 
between sialic acid and CRP suggesting that these inﬂ  amma-
tory markers occur independent of each other.
We conclude that the increased serum sialic acid con-
centration and microalbumin in diabetics with and without 
nephropathy positively correlates with systolic blood pres-
sure and waist-to-hip ratio. These ﬁ  ndings suggest the use of 
microalbumin, serum sialic acid and waist to hip ratio along 
with blood pressure measurement to protect the diabetic 
patients from developing cardiovascular complications. Such 
investigations can not only improve the quality of life but 
also reduce mortality in diabetic patients in Trinidad.
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